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Abstract
In the present study, by comparing the responses in wild-type mice (iNOSWT) and mice lacking (iNOSKO) the
inducible (or type 2) nitric oxide synthase (iNOS), we investigated the correlation between endogenous nitric oxide
(NO) and prostaglandin (PG) generation in carrageenan-induced pleurisy. The inflammatory response in iNOSKO
mice was significantly reduced in respect to iNOSWT animals, as demonstrated by the exudate volume ( 63%)
and numbers of infiltrating cells ( 62%). The levels of NOx in the pleural exudate from carrageenan-treated mice
were significantly (p < 0.01) decreased in iNOSKO mice (16 F 7.6 nmoles/mice) compared to iNOSWT animals
(133 F 9 nmoles/mice). Similarly, the amounts of PGE2 in the pleural exudates of carrageenan-treated animals
were significantly (p < 0.01) lower in iNOSKO compared to iNOSWT mice (120 F 20 pg/mice vs. 308 F 51
pg/mice). Also the amounts of 6-keto-PGF1a produced by lungs from carrageenan-treated iNOSKO mice (1.01 F
0.10 ng/tissue mg) were significantly (p < 0.01) reduced compared to iNOSWT carrageenan-treated mice (2.1 F
0.09 ng/tissue mg). In conclusion our results confirm, by the use of iNOSKO mice that in carrageenan-induced
pleurisy NO positively modulates PG biosynthesis.
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Introduction
Nitric oxide (NO) is a pleiotropic mediator formed from L-arginine by nitric oxide synthase (NOS).
Several major isoforms of NOS have been identified. Two Ca2 +/calmodulin-dependent isoforms are
constitutively expressed in the endothelium of blood vessel (eNOS or type 3 NOS) and in the neurons of
the brain (nNOS or type 1 NOS) and release NO under physiological conditions. The Ca2 +/calmodulin
independent isoform (iNOS or type 2 NOS) is expressed following its transcriptional induction by pro-
inflammatory cytokines and bacterial wall components in different cell types such as macrophages,
neutrophils, endothelial and smooth muscle cells [1,2]. Enhanced formation of NO following the
induction of iNOS has been implicated in the pathogenesis of shock and inflammation [2].
Enhanced arachidonic acid metabolism generally accompanies inflammation and tissue injury.
Biochemical and pharmacological data support the existence of two isoforms of cyclooxygenase
(COX), the enzyme which converts arachidonic acid to prostaglandins (PGs). The constitutive isoform
(COX-1), which is present in most cells and tissues, regulates many physiological functions through the
release of PGs, while the inducible isoform (COX-2), which is induced at the inflammation site by
inflammatory and/or immunological stimuli, seems to be responsible of the elevated PG generation
which characterizes the inflammatory process [3–5].
The exposure to inflammatory mediators such as cytokines and endotoxin (LPS) leads to the induction
of both COX-2 and iNOS [6,7]. This co-induction has encouraged researchers to look for a possible
cross talk between the NOS and COX pathways. It has been reported from in vitro and ex vivo
experiments that the production of large amounts of NO decreased PG generation [6,8–11]. Conversely,
using similar experimental models in vitro and ex vivo, we and others have found that NO increases PG
biosynthesis [12–17]. In support of these latter studies, experiments in LPS-treated rats and in rats
subjected to acute inflammation (peritonitis and paw oedema) have led to the suggestion that also NO
produced by iNOS in vivo positively regulates PG generation [18–21]. Unfortunately these previous
investigations were limited by the lack of highly selective iNOS inhibitors. This is particularly relevant
for the in vivo studies, where all the three isoforms of NOS are present [22], and where NO produced by
eNOS is central to the regulation of regional blood flow and systemic blood pressure [22]. In this study,
we have investigated the cross talk between the NOS and COX systems in carrageenan-induced pleurisy,
using knockout mice for iNOS (iNOSKO). It has been previously demonstrated that, in this model of
acute inflammation, COX-2 and iNOS are the predominant isoforms of their respective enzymes, with a
similar profile of activity [23]. Moreover in the same experimental model it has been shown that either
the potentiation or the inhibition of NO generation produced a corresponding increase or decrease in
PGE2 biosynthesis [24]. In this study we have determined, after pleurisy induction by carrageenan, the
following endpoints of the inflammatory response in iNOSKO mice and in corresponding wild-type
(iNOSWT) mice: (1) exudate formation, (2) polymorphonuclear (PMN) infiltration in the pleural cavity,
(3) NOx and PGE2 levels in the exudate and 6-keto-PGF1a amount in lung tissue.
Methods
Animals
Male iNOSKO and iNOSWT mice (20–25 g, kindly supplied by Fons A.J. Van de Loo, Department
of Rheumatology, University Hospital Nijmegen, Nijmegen, The Netherlands) were used. All animals
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were allowed access to food and water ad libitum. Animal care was in compliance with Italian
regulations on protection of animals used for experimental and other scientific purposes (D.M. 116192)
as well as with the EEC regulations (O.J. of E.C. L 358/1 12/18/1986).
Carrageenan-induced pleurisy
Mice were anaesthetized with isoflurane and submitted to a skin incision at the level of the left sixth
intercostals space. The underlying muscle was dissected and 0.1 ml saline (sham group) or 0.1 ml saline
containing 2% E-carrageenan (carrageenan group) were injected into the pleural cavity. At 4 h after the
injection of saline or carrageenan, the animals were killed by inhalation of CO2. The chest was carefully
opened and the pleural cavity rinsed with 1 ml of saline solution containing heparin (5 U/ml) and
indomethacin (10 Ag/ml). The exudate and washing solution were removed by aspiration and the total
volume measured. Any exudate, which was contaminated with blood was discarded. The amount of
exudate was calculated by subtracting the volume of the saline solution (1 ml) from the total volume
recovered. The leukocytes in the exudate were suspended in phosphate-buffer saline (PBS) and counted
with an optical microscope in a Burker’s chamber after vital Trypan Blue staining.
Measurement of nitrite + nitrate (NOx) in pleural exudate
Nitrite + nitrate (NOx) production, an indicator of NO synthesis, was measured in the pleural exudate
as previously described [21]. Briefly, the nitrate in the samples was first reduced to nitrite by incubation
with nitrate reductase (670 mU/ml) and NADPH (160 AM) at room temperature for 3 h. The nitrite
concentration in the samples was then measured by the Griess reaction, by adding 100 Al of Griess
reagent (0.1% naphthylethylenediamine dihydrochloride in H2O and 1% sulphanilamide in 5%
concentrated H2PO4; vol. 1:1) to 100 Al samples. The optical density at 550 nm (OD550) was measured
using ELISA microplate reader (SLT-Labinstruments Salzburg, Austria). Nitrite concentrations were
calculated by comparison with OD550 of standard saline.
Measurement of prostaglandin E2 in pleural exudate
The amount of prostaglandin E2 (PGE2) present in the pleural fluid was measured by radioimmuno-
assay (RIA) without prior extraction or purification [25] and expressed as pg/mice.
Measurement of 6-keto-PGF1a in lung tissue
Lungs obtained at 4 h after the induction of pleurisy by carrageenan injection were immediately
homogenised and processed as described by Westcott et al. [26]. The amount of 6-keto-PGF1a present in
the lung homogenate was measured by RIA as previously described [25] and expressed as ng/tissue mg.
Measurement of COX-2 mRNA expression using RT-PCR
RT-PCR was carried out on lung tissues collected 4 h after carrageenan administration. Following
careful washing, total RNA was purified from approximately 200 mg of each tissue and reverse
transcribed into cDNA as previously reported [27]. PCR amplification of cDNA product was carried out
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using COX-2 specific primers. The mRNA for the constitutive GAPDH enzyme was examined as the
reference transcript. GAPDH mRNA amplification products (195 bp) were present at equivalent levels in
all tissue lysates.
Estimates of the relative COX-2 mRNA amounts were obtained dividing the area of the COX-2 band
by the area of the GAPDH band (Bio-Rad Multi-Analyst/PC Version 1.1).
Data analysis
All values in the figures and text are expressed as mean F SEM of the mean of n observations, where
n represents the number of animals studied. Data sets were examined by one- and two-way analysis of
variance. Individual group means were then compared with Student’s unpaired t-test. A p-value less than
0.05 were considered significant.
Materials
[3H]-PGE2 (specific activity 170 Ci/mmol) and [
3H]-6-keto-PGF1a (specific activity 130 Ci/mmol)
were from Du Pont de Nemours Italiana (Cologno Monzese, Italy). Antisera for both compounds were a
kind gift of Prof. G. Ciabattoni (Catholic University, Rome, Italy). All other reagents and compounds
used were obtained from Sigma Chemical Company (Sigma, Milan, Italy).
Results
Exudate volume and cell count
Injection of 0.1 ml of 2% E-carrageenan into the pleural cavity of iNOSWT mice caused a significant
accumulation of the inflammatory exudate in respect to iNOSWT sham animals. As shown in Table 1 the
average volume of exudate for iNOSWT mice was 1.1 F 0.13 and 0.12 F 0.06 ml/mice (p < 0.01) in
carrageenan-treated and sham animals, respectively. Total leucocytes number migrated into the pleural
cavity was 66 F 1.3  106 in carrageenan-treated iNOSWT mice and 1.2 F 0.6  106 in sham
iNOSWT animals (p < 0.01). Carrageenan-treated iNOSKO mice showed a significant (p < 0.01)
Table 1
Exudate volume and number of emigrated cells in pleural cavity at 4 h after carrageenan injection
Volume (ml) Polymorphonuclear (million cells/mice)
Sham Carrageenan Sham Carrageenan
iNOSWT 0.12 F 0.06 1.1 F 0.13* 1.2 F 0.6 66 F 1.3*
iNOSKO 0.11 F 0.08 0.41 F 0.11#,B 1 F 0.8 25 F 1.1##,B
Data are means F SEM of 10 mice for each group.
*p < 0.01 vs iNOSWT sham.
# p < 0.05 vs iNOSKO sham.
## p < 0.01 vs iNOSKO sham.
B p < 0.01 vs iNOSWT carrageenan.
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reduction ( 63%) of the pleural exudate as well as the number of emigrated PMNs ( 62%) in respect
to iNOSWT carrageenan-treated mice, although a significant increase of both pleural exudate and
infiltrated cells was observed in respect to iNOSKO sham animals (Table 1).
Nitrite + nitrate (NOx) and PGE2 in pleural exudate
The levels of NOx (NO2
 + NO3
) were significantly (p < 0.01) increased in the exudate from
carrageenan-treated iNOSWT mice when compared to iNOSWT sham mice (Fig. 1A). The NOx levels
found in the exudate of carrageenan-treated iNOSKO animals were significantly (p < 0.01) decreased
Fig. 1. Nitrite + nitrate (NOx) (A) and PGE2 (B) levels in pleural exudate at 4 h after carrageenan administration. Data
are expressed as nmoles/mice for NOx and pg/mice for PGE2 and represent the means F SEM of 10 mice for each group.
*p < 0.01 vs iNOSWT sham. Bp < 0.01 vs iNOSWT carrageenan.
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by about 88% compared to carrageenan-treated iNOSWT mice and similar to what observed in iNOSKO
sham animals (Fig. 1A).
The amount of PGE2 found in the pleural exudate from either iNOSWT or iNOSKO sham animals
were under the least detectable concentration of the RIA (6 pg/ml). In carrageenan-treated iNOSKO mice
the levels of PGE2 were significantly (p < 0.01) lower, by about 61%, compared to carrageenan-treated
iNOSWT mice (Fig. 1B).
Amount of 6-keto-PGF1a in lung tissue
A significant increase was observed in both iNOSWT and iNOSKO lungs from carrageenan-treated
mice compared to the respective sham group. When the amount of 6-keto-PGF1a detected in the lungs
from carrageenan-treated iNOSWT mice was compared to that observed in the tissues from carrageenan-
treated iNOSKO animals a significant (p < 0.01) reduction, by about 52%, was observed. However the
amount of the prostanoid detected in lung from iNOSWT and iNOSKO sham animals was not
statistically different (Fig. 2).
Fig. 2. Amount of 6-keto-PGF1a in the lung at 4 h after carrageenan injection. Data are expressed as ng/tissue mg and represent
the means F SEM of 10 mice for each group. *p < 0.01 vs iNOSWT sham. #p < 0.05 vs iNOSKO sham. Bp < 0.01 vs
iNOSWT carrageenan.
Fig. 3. Gene expression of COX-2 in the mice lung after vehicle or carrageenan administration.
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COX-2 mRNA expression
Although the gene expression of COX-2 was negligible in the normal lung collected from iNOSWT
mice, the expression of COX-2 mRNA was found to be up-regulated in the lung from carrageenan-
treated iNOSWT mice, the expression was clearly detected in the lung as early as 4 h after the
carrageenan administration (Fig. 3). The up-regulation of COX-2 was similarly observed in the lung
collected from carrageenan-treated iNOSKO mice (Fig. 3).
Discussion
COX is the rate-limiting enzyme involved in the biosynthesis of prostaglandins, thromboxane A2 and
prostacyclin. In addition to the well characterized constitutive form of COX (COX-1) [28] an inducible
isoform (COX-2) is present in endothelial cells [29], fibroblasts [30], and macrophages [3,4] after
treatment with pro-inflammatory agents including LPS and IL-1h. Regulation of this enzyme shares
similarities with the regulation of iNOS [17] and is also under the regulation of nuclear factor kappa B
(NFkB) and MAP kinase [31,32]. A cross talk between NOS and COX pathways has been suggested by
many studies. Thus NO has been reported to either negatively or positively modulate PG generation (for
review see Refs. [33,34]).
In this study, we have shown that in carrageenan-induced pleurisy, almost in the absence of NO
production, as in iNOSKO mice, PGE2 generation in the pleural exudate was significantly decreased, by
about 61%, compared to what was observed in iNOSWT mice. Thus PG generation at the inflammation
site seems to be, at least in part, under the control of NO. The lack of NO generation in iNOSKO mice is
demonstrated by the levels of NOx found in the pleural exudates of carrageenan-treated mice, which
were similar to what was observed in sham animals. In fact in carrageenan-induced pleurisy NO is
strongly generated by the iNOS, which is the predominant isoform [23]. Thus our results suggest that the
action of NO on PG biosynthesis seems to be dependent on iNOS induction. These results are in
agreement with previous data, obtained in rat carrageenan pleurisy [24] and in other models of acute
inflammation [14,16,19–21] showing that the modulation of NO pathway, either by inhibiting, with
NOS inhibitors, or increasing, with L-arginine or NO donors, NO generation corresponds to a parallel
modulation of PG biosynthesis. Moreover in the lung of carrageenan-treated iNOSKO mice we observed
a 52% decrease in 6-keto-PGF1a generation compared to iNOSWT animals. Thus the lack of NO
generation, due to the absence of iNOS expression, which is present in the lung from iNOSWT animals
treated with carrageenan [35], is correlated with decreased prostanoid production. No difference in PG
production was observed in the lung of iNOSWT and iNOSKO sham animals, suggesting that NO does
not affect the unstimulated release of the prostanoid. These results are in agreement with previous data,
obtained in another model of inflammation in the rat lung [16]. The effect of null iNOS genotype on
COX enzyme has been investigated in different experimental models with different results. PG formation
by stimulated peritoneal macrophages from iNOS-deficient mice was decreased compared to cells from
wild type animals as well as PG levels in the urine [36] suggesting a positive correlation. Similar positive
correlation was found concerning the antinociceptive effect of iNOS deletion which correlated with loss
of stimulation of PG biosynthesis, probably through an action on COX activity [37]. On the contrary, in
a mouse model of familial adenomatous polyposis no correlation between the antitumorigenic role of
iNOS and COX-2 expression and activity was found [38].
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The mechanism of action of NO in the modulation of PG biosynthesis is still under debate. In the
present study we demonstrate that the genetic inhibition of iNOS (iNOSKO mice) did not modify the up-
regulation of the expression of COX-2 mRNA in the lung after carrageenan administration. These results
demonstrate that in the carrageenan-induced acute lung inflammation NO modulates PG biosynthesis
interfering with COX-2 activity and not at the expression level of the enzyme. Therefore, several
mechanisms have been suggested in different experimental models. In rat mesangial cells and human
lung epithelial cells NO seems to modulate, at least in part, PG generation stimulated by IL-1h, by
potentiating COX-2 mRNA and protein expression [17]. Other reports (for review see Ref. [39]) have
suggested that NO may act, at least in part, both at transcriptional and post-transcriptional levels.
However other study [40] has been reported that ischemia-induced PGE2 biosynthesis, in the brain, was
significantly reduced in iNOS knockout mice compared with wild-type animals, although COX-2
expression was not reduced, thus suggesting a direct interaction between NO and COX. Stimulation of
PG biosynthesis by a direct interaction between NO and COX has been indicated by other studies,
although the type of interaction has not been clearly elucidated [39].
Conclusion
In conclusion, our results demonstrate that in the carrageenan-induced acute lung inflammation NO
modulates PG biosynthesis interfering with COX-2 activity and not at the expression level of the
enzyme. Therefore, we demonstrate by the use of iNOSKO mice, that in carrageenan-induced pleurisy
NO positively modulates PG biosynthesis and that the pro-inflammatory action of NO seems to be also
related to the cross talk with the COX pathway.
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